Artificial Intelligence | Machine Learning | Machine Perception Whitelab Genomics | AI/ML for Genomic Therapies


Enterprise, Biotherapies, Gene Therapy, RNA Therapy, Cell Therapy Paris , France

Whitelab Genomics

Artificial Intelligence | Machine Learning | Machine Perception


Whitelab Genomics | AI/ML for Genomic Therapies

Whitelab Genomics

Biotherapies, Gene Therapy, RNA Therapy, Cell Therapy


Paris , France

Our proprietary platform leverages graph knowledge technology and machine learning to help our customers discover and design new genomic therapies. Based on exhaustive datasets, the platform provides in-silico simulations to discover and design optimized payloads and vectors. Thanks to our advanced software solutions and proprietary database, scientists in the field of genomic medicine are able to obtain precise and exhaustive answers to key scientific and technological questions such as optimizing payload and vector design, assessing genotoxicity, and identifying optimal experimental protocols for in vivo and in vitro strategies.

Gene therapy is a revolutionary treatment designed to introduce a functional copy of a gene into cells in place of missing or defective ones in order to correct genetic disorders. Therapeutic effect can be achieved through insertion, deletion, inactivation, or modification of genetic sequences. RNA therapeutics are a new class of medications based on ribonucleic acid (RNA). These drugs can either trigger protein synthesis to promote a new therapeutics effect, such as a vaccine, or they can activate an interfering mechanism in order to suppress pathological protein pathway expression  and block the disease. Cell therapy is a therapy in which viable cells are injected or implanted into a patient to trigger a medicinal effect. These cells are originally collated from a patient, cultured and transformed in vitro with therapeutic genetic material. The transformed cells which have the capability to cure the symptoms are re-injected in the patient. 

 
 

   Total Funding: $10M

   Funding Stage: Seed

   Business Stage: Scaling Up

   Market: B2B

   Company Size: 1 to 25

   Founded: 2019

Jan 2021

  • Partnership: WhiteLab Genomics Partnered with ART-TG
 
 

AI Startups Funding Deals IntelligenceTry for Free

Date

Round

$ Raised

Investors

09/13/2022

Series A

$10M

Debiopharm Innovation Fund, Omnes Capital

Date : 09/13/2022

Round: Series A

$ Raised: $10M

Investors: Debiopharm Innovation Fund, Omnes Capital

 

For AI Startup Founders

Get introduced to VC/PE/CVC investors

For Investors at VC/PE firms

Get introduced to AI Startup founders or founders at Whitelab Genomics

 
 
 
David Bourgo

David Bourgo
CEO co-founder

Julien Cottineau

Julien Cottineau
Chief Scientific Officer CSO

 
 

Whitelab Genomics is growing. Want to work at Whitelab Genomics? Whitelab Genomics is hiring. Join team at Whitelab Genomics

 

View All

Lead Data Scientist

Paris, Paris

Computational Biologist

Paris, Paris

Whitelab Genomics - AI Startup | AI Startup Profile Powered by Appengine AI | Appengine AI - AI Ecosystem of 12,000+ AI Startups appengine.ai Whitelab Genomics - Manage Profile

 
 
 
appengine.ai

World's Most Promising AI Startups





World's Leading AI Ecosystem of AI Startups, Founders, Investors, and AI Professionals


Get Started